Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 12/20 | 0.75 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.52 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | CASP2 | P42575 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10863882 | 0.96 | EPHX1 (0.75) | EPHX1ZDHHC20ZDHHC2EPHX2CASP2 | |
| SCHEMBL8430980 | 0.89 | EPHX1 (0.68) | EPHX1EPHX2 | |
| SCHEMBL9390 | 0.89 | EPHX1 (0.95) | EPHX1EPHX2CASP2 | |
| SCHEMBL11560472 | 0.87 | EPHX1 (0.56) | EPHX1ZDHHC20ZDHHC2EPHX2ALDH1A1 | |
| SCHEMBL25225195 | 0.86 | EPHX1 (1.00) | EPHX1ZDHHC20ZDHHC2EPHX2CASP2 | |
| SCHEMBL25277850 | 0.86 | EPHX1 (1.00) | EPHX1ZDHHC20ZDHHC2EPHX2CASP2 | |
| SCHEMBL25278283 | 0.86 | EPHX1 (1.00) | EPHX1ZDHHC20ZDHHC2EPHX2CASP2 | |
| SCHEMBL25227881 | 0.86 | EPHX1 (1.00) | EPHX1ZDHHC20ZDHHC2EPHX2CASP2 | |
| SCHEMBL25275055 | 0.86 | EPHX1 (1.00) | EPHX1ZDHHC20ZDHHC2EPHX2CASP2 | |
| SCHEMBL25230056 | 0.86 | EPHX1 (1.00) | EPHX1ZDHHC20ZDHHC2EPHX2CASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020032238-A1 | Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-03-14 | — | — | US | claimed |
| US-20020032238-A1 | Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020032238-A1 | Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments | MTTP, CETP, FABP1 | EPHX1 1716/4885ZDHHC20 381/4885ZDHHC2 277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.